Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Trillium Therapeutics Inc. V.SSS

Sector: Healthcare | Sub-Sector: Biotechnology
Primary Symbol: T.TR
Alternate Symbol(s):  SCTPD | SCTPF

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.
Price: N/A Volume: 0
Change: N/A % Change: N/A
Day High/Low: N/A/N/A 52 Week High/Low: N/A/N/A
Last Traded: N/A Transaction Volume:
Open: Previous Close:
Bid: Ask:
Bid Size: 0 Ask Size: 0
Market Cap: N/A Shares Out: 6.8m
PE Ratio: N/A Dividend Yield: N/A

Opinion

Technology that may save lives: Stem Cell Therapeutics

Stock has been fairly range-bound in terms of price since last May

AllPennyStocks.com   March 16, 2009
0 stars

Latest Bullboard Posts